Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;32(1):254-261.
doi: 10.1007/s00330-021-08148-6. Epub 2021 Jul 13.

Assessment of tumor depth in oral tongue squamous cell carcinoma with multiparametric MRI: correlation with pathology

Affiliations

Assessment of tumor depth in oral tongue squamous cell carcinoma with multiparametric MRI: correlation with pathology

Weiqing Tang et al. Eur Radiol. 2022 Jan.

Abstract

Objectives: To compare the correlation of depth of invasion (DOI) measured on multiple magnetic resonance imaging (MRI) sequences and pathological DOI, in order to determine the optimal MRI sequence for measurement.

Methods: A total of 122 oral tongue squamous cell carcinoma (OTSCC) patients were retrospectively analyzed, who had received preoperative MRI and surgical resection. DOIs measured on fat-suppressed T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), dynamic enhanced-T1 high-resolution insotropic volume examination (e-THRIVE), and contrast-enhanced fat-suppressed T1WI (CE-T1WI) were respectively compared to those measured in pathologic specimens. The cutoff value of the best correlated MRI sequence was determined, and the T staging accuracy of MRI-derived DOI was evaluated.

Results: DOI derived from e-THRIVE showed the best correlation (r = 0.936, p < 0.001) with pathological DOI. The area under the curve values of MRI-derived DOI distinguishing T1 stage from T2 stage and distinguishing T2 stage from T3 stage were 0.969 and 0.974, respectively. The T staging criteria of MRI-derived DOI were 6.2 mm and 11.4 mm, with a staging accuracy of 86.9% compared to pathological DOI criteria of 5 mm and 10 mm.

Conclusion: E-THRIVE was the optimal MR sequence to measure the MR-derived DOI, and DOI derived from e-THRIVE could serve as a potential cut-off value as a clinical T staging indicator of OTSCC.

Key points: • Multiparametric MRI helps radiologists to assess the neoplasm invasion in patients with oral tongue squamous cell carcinoma. • Retrospective study indicated that measurement was most accurate on enhanced-T1 high-resolution insotropic volume examination dynamic contrast enhancement images. • T staging of oral tongue squamous cell carcinoma was accurate according to the dynamic contrast enhancement MRI-derived depth of invasion.

Keywords: Multiparametric MRI; Neoplasm Invasion; Oral tongue squamous cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Figures

Fig. 1
Fig. 1
A 55-year-old male with OTSCC in the right border of tongue. The pathological DOI was 7.0 mm. The DOIs measured on T2WI, DWI, e-THRIVE, and CE T1WI were 15.0 mm, 8.1 mm, 8.6 mm, and 15.6 mm, respectively. a The schematic diagram of DOI measurement on T2WI. b On ADC map, the tumor showed hypointensity (white star) and edema showed hyperintensity (black star). c The tumor showed significant enhancement on the e-THRIVE. The margin of tumor was well-defined (black arrow). d Both tumor and perilesional edema showed hyperintensity on contrast-enhanced T1WI
Fig. 2
Fig. 2
Correlation between each MRI sequence based DOI and pathological DOI. a T2WI. b DWI. c E-THRIVE. d CE T1WI
Fig. 3
Fig. 3
ROCs for the differentiating performance of e-THRIVE-derived DOI among the defined groups of OTSCC based on the eighth edition of the AJCC staging. a T1 stage vs. T2 stage. b T2 stage vs. T3 stage

Similar articles

Cited by

References

    1. Ettinger KS, Ganry L, Fernandes RP. Oral cavity cancer. Oral Maxillofac Surg Clin North Am. 2019;31:13–29. doi: 10.1016/j.coms.2018.08.002. - DOI - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30. doi: 10.3322/caac.21442. - DOI - PubMed
    1. Koo BS, Lim YC, Lee JS, Choi EC. Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity. Oral Oncol. 2006;42:789–794. doi: 10.1016/j.oraloncology.2005.11.016. - DOI - PubMed
    1. Ling W, Mijiti A, Moming A. Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue: a retrospective analysis of 210 cases. J Oral Maxillofac Surg. 2013;71:775–785. doi: 10.1016/j.joms.2012.09.026. - DOI - PubMed
    1. Tan WJ, Chia CS, Tan HK, Soo KC, Iyer NG. Prognostic significance of invasion depth in oral tongue squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec. 2012;74:264–270. doi: 10.1159/000343796. - DOI - PubMed

MeSH terms